- US12595284utility2026Amatoxin Antibody-drug Conjugates and Uses Thereof0 cites
- US12576158utility2026Antibody Drug Conjugates with Cleavable Linkers0 cites
- US12544419utility2026Targeted Amatoxin Conjugate for the Treatment of Solid Tumors0 cites
- US12403185utility2025Use of Anti-cd137 Antibody Drug Conjugate (ADC) in Allogeneic Cell Therapy0 cites
- US12403201utility2025B-lymphocyte Specific Amatoxin Antibody Conjugates0 cites
- US12378196utility2025Synthesis of (s)-6-hydroxytryptophan and Derivatives Thereof0 cites
- US12251448utility2025Compositions and Methods for the Depletion of CD5+ Cells0 cites
- US12201693utility2025Amanitin Conjugates0 cites
- US12006370utility2024Use of Anti-cd5 Antibody Drug Conjugate (ADC) in Allogeneic Cell Therapy0 cites
- US11976131utility2024Humanized Antibodies Against PSMA0 cites
- US11926631utility2024Method of Treating Cancer Using Amanitin Derivatives0 cites
- US11702451utility2023Method for Synthesizing Amanitins0 cites
- US11590238utility2023Amanitin Conjugates0 cites
- US11583569utility2023Psma-targeting Amanitin Conjugates0 cites
- US11584708utility2023Synthesis of (2s,3r,4r)-4,5-dihydroxyisoleucine and Derivatives0 cites